Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus

Status unconfirmed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Progressive Keratoconus

In brief

Clinical Trial to Evaluate the Safety and Efficacy of Corneal Cross-linking in Subjects with Keratoconus.

Key facts

Study ID

NCT05314738

Run by

Glaukos Corporation

People needed

150

Starts

2022-03-08

Expected to finish

2026-02-01

Last updated by the study team

2024-07-08

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Provide written informed consent
• Ability to hold gaze sufficiently stable for study testing
• Willingness and ability to follow all instructions and comply with schedule for follow-up visits
• Have a diagnosis of keratoconus

You may not qualify if…

• Known allergy or sensitivity to the test articles or components
• Any disease causing abnormal topography other than keratoconus
• Prior or current ocular condition (other than keratoconus) in the study eye that may predispose the eye for future complications

Where it is running

• Glaukos Investigative Site — Dothan, Alabama, United States (enrolling)
• Glaukos Investigative Site — Teaneck, New Jersey, United States (enrolling)
• Glaukos Investigative Site — Westerville, Ohio, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.